Amylinʼs physiology and its role in diabetes
The DOI matches its Crossref record.
Abstract
Amylin is a 37-amino-acid peptide hormone cosecreted with insulin from pancreatic β cells. In contrast to insulin, which controls plasma glucose concentrations primarily by increasing the rate of glucose disappearance, amylin appears to control plasma glucose via several mechanisms that reduce the rate of glucose appearance in plasma. By its effect on food intake, amylin limits nutrient inflow into the gut. By its effect on gastric emptying, it limits nutrient flux from gut to blood, and by its ability to suppress glucagon secretion, it is predicted to moderate the flux of glucose from liver to blood. Amylin is absolutely or relatively deficient in type I diabetes and in insulin-requiring type II diabetes. Amylin hormone replacement with an amylin agonist, such as the synthetic human amylin analogue, pramlintide, may, by mechanisms such as the preceding, assist in achieving metabolic control in individuals with type I and insulin-requiring type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucose Metabolism and Regulation: Beyond Insulin and Glucagon
Aronoff, S. L., Berkowitz, K., Shreiner, B., & Want, L. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.3.183 · Cited by 569
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01319.x · Cited by 307
Whitehouse, F., Kruger, D. F., Fineman, M., Shen, L., Ruggles, J. A., Maggs, D. G., Weyer, C., & Kolterman, O. G. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.724 · Cited by 264
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
Chapman, I., Parker, B., Doran, S., Feinle-Bisset, C., Wishart, J., Strobel, S., Wang, Y., Burns, C., Lush, C., Weyer, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1732-4 · Cited by 205
“dorsal raphe and area postrema [19–21], and exerts various glucoregulatory and anorexigenic effects [18].”
BackgroundInfluential
Metadata
- Authors
- Young, A. A.
- Venue
- Current Opinion in Endocrinology and Diabetes
- Published
- 1997-08
- Volume
- 4
- Issue
- 4
- Pages
- 282-290
- ISSN
- 1068-3097 (ISSN-L)
- OpenAlex
- W2326971529
- Cited by
- 87
- References
- 0
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amylinʼs physiology and its role in diabetes. https://app.cochat.ai/papers/10.1097/00060793-199708000-00006
- The paper
- Young, A. A. (1997). Amylinʼs physiology and its role in diabetes. Current Opinion in Endocrinology and Diabetes. https://doi.org/10.1097/00060793-199708000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.